Correction: In Vivo Evaluation of Almotriptan Malate Formulation Through Intranasal Route for the Treatment of Migraine: Systematic Development and Pharmacokinetic Assessment
Shubham Gupta(University Hospitals of Cleveland), Derajram Benival(Department of Pharmaceuticals), Hemant Kumar(National Institute of Pharmaceutical Education and Research - Ahmedabad), Jyotsna Vitore(National Institute of Pharmaceutical Education and Research - Ahmedabad), Abhishek Roy(National Institute of Pharmaceutical Education and Research - Ahmedabad), Akhil Perla(National Institute of Pharmaceutical Education and Research - Ahmedabad), Sagar Salave(National Institute of Pharmaceutical Education and Research - Ahmedabad), Amit Sharma(National Institute of Pharmaceutical Education and Research - Ahmedabad), Dhwani Rana(National Institute of Pharmaceutical Education and Research (NIPER) - Ahmedabad), K. Bharathi(National Institute of Pharmaceutical Education and Research - Ahmedabad), Rajeshwari Rathod(National Institute of Pharmaceutical Education and Research - Ahmedabad)
Cited by 0
Related Papers
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape
|Small|2025|166
Recent Advancements in Microneedle Technology for Multifaceted Biomedical Applications
|Pharmaceutics|2022|126
Estimation of carvedilol in human plasma by using HPLC-fluorescence detector and its application to pharmacokinetic study
|Journal of Chromatography B|2007|41
Green Analytical Chemistry and Quality by Design: A Combined approach towards Robust and Sustainable Modern Analysis
|Current Analytical Chemistry|2018|41
Simultaneous HPLC–UV determination of rhein and aceclofenac in human plasma
|Journal of Chromatography B|2009|34